Comparable efficacy of ibalizumab in combination with 1 or 2 fully active agents.
Oct 25, 2020
25 Oct 2020
DeJesus E, McGary C, Mesquita P, et al.
Location
Poster #507 presented at: Conference on Retroviruses and Opportunistic Infections; March 8-11, 2020; Boston, Massachusetts, USA.